66 results
Page 3 of 4
8-K
EX-99.1
0019 jiv0v
26 Mar 20
NeuBase Therapeutics Reports Financial Results for the First Fiscal Quarter of 2020
4:06pm
8-K
EX-99.1
bi67gs
9 Jan 20
NeuBase Therapeutics Reports Financial Results for Fiscal Year 2019
4:06pm
424B3
sl19fb32svw38yu
23 Sep 19
Prospectus supplement
5:05pm
424B3
6z4xswm twfh
6 Jun 19
Prospectus supplement
5:15pm
S-4/A
nk3ryn0u8wzq8kdxge
16 Apr 19
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4
ha7z3pjh
8 Mar 19
Registration of securities issued in business combination transactions
5:12pm
8-K
EX-99.2
e7wnx731
3 Jan 19
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
cm36tf5j3uledt0 q7lt
3 Jan 19
Entry into a Material Definitive Agreement
5:29pm
425
EX-99.2
30fzkgam9xaoy26 hhm
3 Jan 19
Business combination disclosure
5:28pm
425
EX-99.1
0a8byhaui 2eyzx5g9s
3 Jan 19
Business combination disclosure
5:28pm
8-K
EX-99.1
j2qegcignw71 yn
14 Oct 14
Ohr Pharmaceutical Announces Successful End of Phase II Meeting with the FDA on Squalamine Eye Drops (OHR-102) in Wet AMD
12:00am
8-K
EX-99.1
oaz0yokx
29 May 12
Regulation FD Disclosure
12:00am
10-K
d12k2ge7u40x d75
13 Jan 09
Annual report
12:00am
8-K
ggvd4axknfr
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am